Melafind, a groundbreaking diagnostic tool that helps detect melanoma, recently became the first and only FDA-approved diagnostic tool that uses multi-spectral light technology and advanced computer algorithms to provide dermatologists with unique data about irregular moles. With its new FDA approval, MelaFind serves as a quick, non-invasive and painless tool for patients. Want to read more? Subscribe to one of our monthly plans to continue reading this article.